LRP6 and glioblastoma: A previous study reported that miR-577 inhibits the growth of glioblastoma multiforme via modulating the Wnt/β-catenin pathway; both β-catenin and LRP6, two crucial components of the Wnt/β-catenin signaling, are directly targeted by miR-577 (22).